logo

Windtree Therapeutics has signed a $520 million new financing agreement, which will be used to purchase BNB.

By: theblockbeats.news|2025/07/25 03:22:18

BlockBeats News, July 25th, Nasdaq-listed biotechnology company Windtree Therapeutics (WINT) announced that it has entered into a share purchase agreement of up to $500 million to establish an Equity Line of Credit (ELOC). Additionally, the company has also signed an additional $20 million stock purchase agreement with Build and Build Corp.

The total funding size of this round reaches up to $520 million, with 99% of the funds to be used to purchase BNB. The company plans to officially start using the funds after obtaining shareholder approval to increase the number of authorized common shares.

Nano Labs appoints Ms. Yang Can as Senior Vice President of Subsidiary to Strengthen Digital Currency Reserve Strategy
A whale bought 1862 ETH 8 hours ago, with an average purchase price of $3750.63

You may also like

Share
copy

Gainers

Latest Crypto News

17:46

Trump Says Fed Chair Should Cut Interest Rates, Reiterates Criticism of Powell

17:15

In the past 24 hours, the entire network liquidated $376 million, with the majority coming from the largest short position

17:15

The probability of a 25 basis point interest rate cut by the Federal Reserve in December is currently at 87.2%.

17:15

Trump: Will Announce New Fed Chair in Early Next Year

17:15

Coinbase International Site to Launch DASH Perpetual Contract Trading

Read more
Community
icon
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MM[email protected]

VIP Services[email protected]